ப்ரைவேட் பங்கு துணிகர நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரைவேட் பங்கு துணிகர நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரைவேட் பங்கு துணிகர நிதி Today - Breaking & Trending Today

The UK is still the top fintech hub in Europe with $4.1bn in funding

Financial News
The UK is still the top fintech hub in Europe with $4.1bn in funding
Companies based in London accounted for more than 90% of the UK s total fintech investment
Silicon Roundabout in London. The capital generates 90% of the UK s fintech funding
Getty Images
By
Wednesday January 20, 2021 12:01 am
The UK has retained its spot as the top destination for fintech venture capital investment in Europe, raking in $4.1bn as a sector in 2020.
Data from Innovate Finance published on 20 January showed the UK ranked second globally for funding last year, behind the US at $22bn. It surpassed emerging markets Indonesia and India, which came third and fourth, respectively. ....

United Kingdom , City Of , Innovate Finance , Venture Capital , Banking Credit , Financial Services , Financial Technology , Money Transfer Currency Exchange Services , Corporate Funding , Corporate Industrial News , Private Equity Venture Funding , Content Types , Factiva Filters , C Ampe Industry News Filter , Industrial News , Private Equity , Venture Funding , Money Transfer , Currency Exchange Services , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , புதுமை நிதி , நிதி திரட்டல் , துணிகர மூலதனம் , வங்கி கடன் , நிதி சேவைகள் ,

ArcLight-Backed SPAC Connects With E-Bus Maker Proterra

Jan. 12, 2021 7:45 pm ET
A blank-check company backed by energy investment firm ArcLight Capital Partners agreed to acquire and take public electric vehicle company Proterra Inc. in a deal that gives it an enterprise value of about $1.6 billion.
ArcLight Clean Transition Corp. , the special-purpose acquisition company, will use $278 million raised through an initial public offering in September as well as $415 million being raised in a private investment in public securities transaction to help finance the deal, regulatory filings show. The deal is expected to close in the first half of the year.
Shares of the blank-check company, which priced its IPO at $10 a share and closed Monday at $12.19 each, more than doubled on Tuesday on news of the deal, closing at $25.20. ....

Elon Musk , Arclight Clean Transition Corp , Proterra Inc , Tesla Inc , Arclight Capital Partners , Light Clean Transition , Motor Vehicles , Commercial Vehicles , Alternative Fuel Vehicles , Trusts Funds Financial Vehicles , Private Equity , Alternative Investments , Business Consumer Services , Financial Services , Investing Securities , Shell Company , Corporate Changes , Regulation Government Policy , Stock Listings , Corporate Funding , Share Capital , Initial Public Offerings , Ownership Changes , Acquisitions Mergers Shareholdings , Conferences Exhibitions , Acquisitions Mergers ,

Start-Up EQRx, Which Wants to Undersell the Drug Industry, Raises Another $500 Million

Order Reprints
Print Article
A pharmaceutical start-up that thinks it can undersell the entire drug industry got off to a quick start in its first year in business, grabbing rights to a handful of drugs, including two that could make it a player in the hottest cancer drug market sometime in the next few years.
Now comes the hard part: Getting doctors to prescribe its cheap drugs, instead of brand-name competitors backed by big marketing budgets.
On.
Close
A Start-Up That Wants to Undersell the Drug Industry Raises Another $500 Million
A pharmaceutical start-up that thinks it can undersell the entire drug industry got off to a quick start in its first year in business, grabbing rights to a handful of drugs, including two that could make it a player in the hottest cancer drug market sometime in the next few years. ....

United States , San Francisco , Alexis Borisy , Josh Nathan Kazis , Peter Bach , Hansoh Pharma , Bristol Myers Squibb , Dmitry Kalinovsky Dreamstime , Health Outcomes , Memorial Sloan Kettering Center , Cstone Pharmaceuticals , Drug Administration , Memorial Sloan Kettering , Healthcare Conference , Casdin Capital , Trusts Funds Financial Vehicles , Private Equity , Healthcare Life Sciences , Alternative Investments , Financial Services , Investing Securities , Venture Capital , Corporate Funding , Corporate Industrial News , Private Equity Venture Funding , Series Round Financing ,